Clinical trial
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating…
NCT01672892 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT01672892 |
|---|---|
| Title | Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer |
| Official title | A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C) |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NRG Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Endometrial Cancer, Gastrointestinal Complications, Perioperative/Postoperative Complications, Radiation Toxicity, Urinary Complications, Urinary Tract Toxicity |
| Intervention type | Radiation |
| Interventions | Standard radiation therapy, intensity-modulated radiation therapy |
| Enrollment | 289 |
| Start date | Nov 1, 2012 |
| Primary completion | Dec 1, 2015 |
| Completion | May 20, 2022 |
| First posted | Aug 27, 2012 |
| Last update posted | Jun 15, 2022 |
| Countries | Canada, Hong Kong, Singapore, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: